Novel dauricine derivatives suppress cancer via autophagy-dependent cell death

Bioorg Chem. 2019 Mar:83:450-460. doi: 10.1016/j.bioorg.2018.10.074. Epub 2018 Nov 2.

Abstract

Eleven dauricine derivatives were synthesized and evaluated for their anti-cancer effect in different cancer cells and their autophagic activity in HeLa model cell. Among these newly synthesized compounds, carbamates 2a, 2b, carbonyl ester 3a and sulfonyl ester 4a exhibited potent cytotoxic effects on tested cancer cells with IC50 values ranged from 2.72 to 12.53 μM, which were more potent than that of dauricine (higher than 15.53 μM). The above four derivatives are validated to induce autophagy-dependent cell death in HeLa cancer cells. These findings offer us a promising source for generating novel autophagic enhancers for anti-cancer therapy.

Keywords: Anti-cancer; Autophagy activator; Bisbenzylisoquinoline alkaloids; Carbamate; Dauricine derivatives.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Autophagy / drug effects
  • Benzylisoquinolines / chemical synthesis
  • Benzylisoquinolines / chemistry
  • Benzylisoquinolines / pharmacology*
  • HeLa Cells
  • Humans
  • Microtubule-Associated Proteins / metabolism
  • Tetrahydroisoquinolines / chemical synthesis
  • Tetrahydroisoquinolines / chemistry
  • Tetrahydroisoquinolines / pharmacology*

Substances

  • Antineoplastic Agents
  • Benzylisoquinolines
  • MAP1LC3B protein, human
  • Microtubule-Associated Proteins
  • Tetrahydroisoquinolines
  • dauricine